These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Early and late-onset effect of chronic stress on vascular function in mice: a possible model of the impact of depression on vascular disease in aging. Isingrini E; Belzung C; d'Audiffret A; Camus V Am J Geriatr Psychiatry; 2011 Apr; 19(4):335-46. PubMed ID: 21427642 [TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of "vascular depression". Taragano FE; Bagnatti P; Allegri RF Int Psychogeriatr; 2005 Sep; 17(3):487-98. PubMed ID: 16252380 [TBL] [Abstract][Full Text] [Related]
7. Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose. Beasley CM; Nilsson ME; Koke SC; Gonzales JS J Clin Psychiatry; 2000 Oct; 61(10):722-8. PubMed ID: 11078032 [TBL] [Abstract][Full Text] [Related]
8. [Assessment of effectiveness of electroacupuncture and fluoxetine for treatment of depression with physical symptoms]. Duan DM; Tu Y; Chen LP Zhongguo Zhen Jiu; 2008 Mar; 28(3):167-70. PubMed ID: 18447212 [TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression. Lee MS; Ham BJ; Kee BS; Kim JB; Yeon BK; Oh KS; Oh BH; Lee C; Jung HY; Chee IS; Choe BM; Paik IH Curr Med Res Opin; 2005 Sep; 21(9):1369-75. PubMed ID: 16197655 [TBL] [Abstract][Full Text] [Related]
12. Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression. Beasley CM; Bosomworth JC; Wernicke JF Psychopharmacol Bull; 1990; 26(1):18-24. PubMed ID: 2196623 [TBL] [Abstract][Full Text] [Related]
13. Risk of prenatal depression and stress treatment: alteration on serotonin system of offspring through exposure to Fluoxetine. Pei S; Liu L; Zhong Z; Wang H; Lin S; Shang J Sci Rep; 2016 Oct; 6():33822. PubMed ID: 27703173 [TBL] [Abstract][Full Text] [Related]
14. Efficacy evaluation for depression with somatic symptoms treated by electroacupuncture combined with Fluoxetine. Duan DM; Tu Y; Chen LP; Wu ZJ J Tradit Chin Med; 2009 Sep; 29(3):167-73. PubMed ID: 19894377 [TBL] [Abstract][Full Text] [Related]
15. A double-blind comparative study of fluoxetine and dothiepin in the treatment of depression in general practice. Corne SJ; Hall JR Int Clin Psychopharmacol; 1989 Jul; 4(3):245-54. PubMed ID: 2677126 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria. Brown MC; Nimmerrichter AA; Guest JF Eur Psychiatry; 1999 Jul; 14(4):230-44. PubMed ID: 10572352 [TBL] [Abstract][Full Text] [Related]
17. Memory loss in a patient treated with fluoxetine. Joss JD; Burton RM; Keller CA Ann Pharmacother; 2003 Dec; 37(12):1800-3. PubMed ID: 14632599 [TBL] [Abstract][Full Text] [Related]
18. Intranasal sumatriptan in post-ECT headache: results of an open-label trial. Markowitz JS; Kellner CH; DeVane CL; Beale MD; Folk J; Burns C; Liston HL J ECT; 2001 Dec; 17(4):280-3. PubMed ID: 11731730 [TBL] [Abstract][Full Text] [Related]